Hookipa Pharma Inc.

13F holders, Q1 2025 (March 31)
1holders
0new positions
0sold out
$1.08avg. 13F price*

At the end of Q1 2025, 1 institutions reported holding Hookipa Pharma Inc. in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Knoll Capital Management, LLC ($539K).

Company
Hookipa Pharma Inc.
CUSIP
43906K100
Latest filing quarter
Q3 2025

History

Number of 13F holders

01020304050 Q1 2024: 47Q1 2024Q2 2024: 39Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Knoll Capital Management, LLC 0.35% No change 498,625 $539K

"% of holder's portfolio" is HOOKIPA PHARMA INC's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.